RxWare is a SaaS company that enables pharmaceutical drug manufacturers to simplify patients' paths to therapy by connecting the siloed patient journey. To improve patient resource utilization and therapy outcomes, the company's Patient Gateway supports a variety of existing patient services and organizations, including ePrescribing systems, Hubs, specialty pharmacies, affordability solutions, system integrators, and nursing vendors. RxWare, which focuses on out-of-the-box connectivity, enables pharmaceutical brands to easily transform complex patient journeys into simple patient experiences. It provides a vendor-neutral digital infrastructure for drug manufacturers to streamline, accelerate, and optimize the entire patient journey. RxWare was founded in 2013.
BCP provides a unique data and technology platform to enable life sciences and healthcare companies to access, manage and analyze clinical and omics data. BCP’s Data Access Platform provides access and related technology to valuable data (RWD, Clinical, Genomics, and Omics) for the Life Science Industry. The Company’s Data Partner Network currently covers more than 22m life-years of highly curated patient data from around the world and is steadily growing. These data are made accessible to Pharma companies through a data-as-a-service (DaaS) model. BCP is able to provide Life Science companies with transformational capabilities to access longitudinal clinical and genome data across the globe to enhance different use cases within the R&D continuum, speeding up the process from early discovery to clinical and post-market access processes. BCP’s technology platform provides technology to Healthcare Providers and Life Science companies to produce, manage and analyze complex genomics as a clinical decision-support solution, analyze the data (genomics- omics and clinical) and make it available for any research ensuring compatibility with all relevant technical standards and in compliance with local privacy law in different jurisdictions.
Octopus.Health is a patient engagement platform for proactive population health. The company technology creates a Healthcare Personal Assistant that supports millions of patients and tailors a personalized proactive healthcare plan for each patient based on advanced machine learning algorithms. Octopus.Health leverages AI and Machine Learning to revolutionize how patient adherence is being managed today. It was founded in 2017 and is based in Tel Aviv, Israel.
Founded in 2015 by noted entrepreneurs Eliran Malki, Irad Deutsch and Ohad Rubin, Belong.life is the world's GenAI leader in healthcare. Belong.life provides Belong – Beating Cancer Together. This free patient navigation app allows cancer patients and their support network to explore and manage their treatment journey while improving their quality of life, and launched PEP, which gives healthcare organizations an end-to-end solution that includes personalized and configurable patient engagement tools, navigation, and management services.
Linguamatics Limited specializes in developing text mining solutions leveraging semantic and natural language processing technology for the life sciences, pharmaceutical, and biotech sectors. The company offers its flagship product, I2E, which facilitates agile querying and reporting, alongside an Asynchronous Messaging Pipeline platform that automates insight discovery from unstructured text. Additionally, Linguamatics Health provides a clinical NLP suite designed for hospitals and research organizations to extract valuable information from electronic health records and patient narratives, ultimately driving healthcare analytics and improving patient outcomes. The software can also be applied in business intelligence, life sciences research, and social media analysis. Founded in 2001 and headquartered in Cambridge, United Kingdom, Linguamatics operates a subsidiary in Newton, Massachusetts, and has a strategic alliance with Selventa, Inc.
Beijing Naxions Technology Co., Ltd. develops a communication software solution that offers digital marketing serivces for the medical Internet industry. The company offers data capture, collection, scraping, cleaning, calculation, and presentation services. The application’s features include content sharing, project management, and customer analysis. The company was founded in 2014 and is based in Chaoyang District, China with additional offices Shanghai, China.
AHM’s solutions have become the standard for more than 25 pharmaceutical companies, managing over 150,000 events annually and having completed over one million pharmaceutical events since 2005. AHM has several hundred employees in 5 office locations around the world. In addition to its industry leading products and services, AHM remains committed to significantly investing in solutions that will provide continuous efficiencies, enhance the customer experience, advance strategic decision making and ensure comprehensive compliance reporting to mitigate risk. There is no one in the industry more committed to invest now and in the future to support its clients.
ObvioHealth is a global digital health organization providing real-world digital clinical trials that deliver better data. Our mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes. For studies designed to include site visits, our application allows for continuous data collection in between visits to the clinic. By bringing the trial directly to the mobile device of each participant, our study team engages subjects daily using text message and chatbot features. This interaction allows for open communication and helps subjects feel involved during virtual clinical trials. The result: robust data collection, increased compliance, faster recruitment and improved time to completion. To assist with collecting real world data in clinical trials, our app can easy link to various health devices. They include Apple watches, Fitbits and activity trackers, along with Bluetooth scales, blood pressure monitors, and smart health apps. Participants can also use the app to schedule lab visits, or connect it with their PayPal account to receive compensation for decentralized clinical trials. And if the study team needs to talk with the participant during mobile clinical trials, the app allows for easy communication through chat or video. Visit Obviohealth.com to learn more about how our technology can help with observational clinical trials and virtual clinical trials.
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.
DrugDev is a family of technology-driven solutions that help doctors, sponsors, and CROs do more clinical trials together. DrugDev brings together the largest online network of clinical trial sites, the leading investigator identification and start-up platform, the industry’s best trial optimization system, and the leading grants payment capabilities to transform the way drug developers find, engage and pay doctors to run clinical trials. DrugDev is also the host of the Investigator Databank, a global collaboration between Lilly, Merck, Pfizer, Janssen, Novartis and DrugDev (with more joining soon) to help increase clinical trial opportunities and reduce the administrative workload for over 200,000 clinical trial doctors worldwide.
Pilgrim Quality Solutions is a world-leading provider of Enterprise Risk, Compliance, and Quality Management software solutions for highly regulated industries. Pilgrim has pioneered effective, integrated software solutions for the Life Science industries, as well as manufacturers in the automotive, aerospace and defense, and other non-FDA regulated industries. Pilgrim’s reputation for excellence in innovation has attracted an impressive portfolio of global customers. More than a half-million end-users employ Pilgrim products every day to meet the diverse challenges of the world’s highly competitive marketplace. Pilgrim’s fully Web-based, integrated solutions help businesses centrally manage domestic and international operations to ensure product safety and compliance, reduce manufacturing costs and improve customer satisfaction.
STI Technologies manages patient support programs and improves medication access by leveraging available reimbursement funding and innovative technology to engage patients in their own healthcare. STI Technologies develops intelligent solutions to assist stakeholders in supporting the healthcare system by providing financial reimbursement, patient engagement, and patient management solutions that improve health outcomes. STI Technologies makes user-friendly solutions available online and through physicians and pharmacists nationwide.
ClioScience
Acquisition in 2015
ClioScience is a drug-raising venture company that develops of anti-cancer drugs and orphan drugs such as doctor-led clinical trials.
Aileron Solutions is a provider of claims based targeting data and longitudinal patient data for pharmaceutical and medical device companies.
Novella Clinical is a specialized contract research organization (CRO) that caters to the unique requirements of small to mid-sized oncology companies, as well as those in the medical device and diagnostics sectors. The company offers a comprehensive range of clinical trial management services, spanning from preclinical stages to post-approval. Novella has developed a flexible business model and possesses global capabilities, with a team of therapeutically-aligned professionals who are well-versed in the specific needs of oncology and medical device trials. This targeted approach allows Novella to effectively support its clients in navigating the complexities of clinical research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.